Loncar Cancer Immunotherapy ETF (CNCR) Surpasses $50 Million in Assets Under Management Feb 16, 2018 08:00AM
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance Dec 20, 2017 08:00AM
Loncar Cancer Immunotherapy Index Announces Merger Replacements Oct 4, 2017 08:00AM
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance Jun 21, 2017 08:30AM
Cancer Immunotherapy ETF (Nasdaq: CNCR) to Ring the Nasdaq Stock Market Opening Bell Oct 28, 2016 03:31PM


Oct 14, 2016 08:30AM Cancer Immunotherapy ETF Celebrates One-Year Anniversary
Jun 22, 2016 07:30AM Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
Dec 16, 2015 07:00AM Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
Dec 1, 2015 09:50AM Loncar Investments Selects Cancer Research Institute as Exclusive Charitable Partner in Immunotherapy Research Donation Program
Oct 14, 2015 09:05AM Market’s Only Cancer Immunotherapy ETF Launches